Search Results

SNNLive - Atossa Genetics, Inc. SNNLive met with Dr.

NEW YORK, Oct. 14, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Western District of Washington on behalf of investors who purchased Atossa Genetics, Inc

While the vast majority of graduate degrees will give you an edge, not all are created equal and some More The 10 most useless graduate degrees The Cadillac Escalade has never lacked for attention. Launched as a rush response to the Lincoln Navigator's More Cadillac reveals the 2015 Escalade, its blingiest land yacht yet Howard Schultz, Starbucks Corp's outspoken CEO, on Monday urged fellow business leaders to ratchet up More Starbucks founder urges CEOs to push for end to federal shutdown New shopping services will allow consumers to instantly buy items they see on television, in magazines More New experiment could take consumer impulsiveness to new heights October 7 marks the date the Motion Picture..

NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky is investigating potential claims on behalf of purchasers of Atossa Genetics, Inc. (Atossa or the Company) (ATOS) securities concerning possible violations of securities laws. For more information, click here: http://zlk.9nl.com/atossa-genetics-atos

SEATTLE, WA--(Marketwired - Aug 22, 2013) - In the news release, "Atossa Genetics and Its Subsidiary the National Reference Laboratory for Breast Health to Exhibit Their Products and Services at Two Upcoming Conferences," issued Wednesday, August 21, 2013 by Atossa Genetics, Inc. (NASDAQ: ATOS), we are advised by the company that the second embedded link of the first paragraph should go to "http://www.survivorsconvention.com/" rather than "http://gaobgyn.com/resources/meeting-events/" as originally issued. Complete corrected text follows

SEATTLE, WA--(Marketwire - Jan 18, 2013) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) announced today that Kyle Guse, chief financial officer, general counsel and secretary, will present at the NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference held at the Hard Rock Hotel & Casino, Hollywood, Florida, on Tuesday, January 22, at 3:00 pm Eastern Time

SEATTLE, WA--(Marketwire - Jan 17, 2013) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) announced today that Steven C.

SEATTLE, WA--(Marketwire - Dec 3, 2012) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) announced today that it has been designated as the Expertise Partner to the 2nd Annual Cancer Genome Summit being held December 4-6, 2012 at the Revere Hotel Boston Common in Boston, Massachusetts.Dr. Steven C.

SEATTLE, WA--(Marketwire - Nov 29, 2012) - Atossa Genetics, Inc.

SEATTLE, WA--(Marketwire - Nov 14, 2012) - Atossa Genetics, Inc.

SEATTLE, WA--(Marketwire - Nov 8, 2012) - Atossa Genetics, Inc. ( NASDAQ : ATOS ) (the "Company") announced today the pricing of its firm commitment, underwritten initial public offering of 800,000 shares of its common stock at a price of $5.00 per share

SEATTLE, WA--(Marketwire -02/14/12)- Atossa Genetics, Inc., a privately-held health care company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions, announced today that it has filed a registration statement on Form S-1 with the United States Securities and Exchange Commission (SEC) relating to a proposed initial public offering of 1,000,000 shares of its common stock. Dawson James Securities, Inc. is acting as sole book-running manager of the offering.

SEATTLE, WA--(Marketwired - Jun 10, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, today announced its support for Are You Dense, Inc., an independent, national breast health advocacy organization dedicated to informing the public about dense breast tissue and its significance for the early detection of breast cancer. Are You Dense, Inc.

SEATTLE, WA--(Marketwired - Apr 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, believes that new recommendations published on April 16 by the U.S. Preventative Services Task Force (USPSTF), suggesting that healthy women at high risk for breast cancer take tamoxifen or raloxifene to prevent the disease, are a major step forward.

67 WALL STREET, New York - March 15, 2013 - The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs and Equity Analysts. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

67 WALL STREET, New York - March 15, 2013 - The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs and Equity Analysts. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

SEATTLE, WA--(Marketwired - Oct 14, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Gregory L. Weaver has joined the Company's Board of Directors and has been appointed a member of the Audit Committee

SEATTLE, WA--(Marketwired - Oct 4, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS), The Breast Health Company, will host a conference call at 5:45 pm Eastern Time today to discuss the Company's voluntary recall of its ForeCYTE Breast Health Test; Mammary Aspiration Specimen Cytology Test (MASCT) System, which was announced today at 5:00 pm Eastern Time. To listen to the call by phone, interested parties within the U.S

SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that Kyle Guse, Chief Financial Officer & General Counsel, will present the Company's products, services and business strategy at the 2013Aegis Capital Healthcare Conference on Friday, September 27, 2013, beginning at 9:45 am Pacific Time.The conference will be held at the Encore at Wynn Las Vegas, 3131 Las Vegas Boulevard South, Las Vegas, Nevada.

SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc.

ATLANTA, GA--(Marketwired - Sep 20, 2013) - Atossa Genetics Inc. (NASDAQ: ATOS) is proud to announce its sponsorship of The Third Annual Power of Pink luncheon, fashion show and silent auction. The event will take place at the Country Club of the South in Johns Creek, Georgia, on Friday, September 20, 2013

SEATTLE, WA--(Marketwired - Sep 19, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, will display its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference & Exhibition from September 19 through September 22, 2013, in Boston, MA. Atossa's exhibit will be located in Booth 903 at the Boston Convention & Exhibition Center

SEATTLE, WA--(Marketwired - Sep 18, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, announced today that it has entered into a nationwide distribution agreement with McKesson Medical-Surgical to sell and distribute Atossa's MASCT device and patient collection kits.

SEATTLE, WA--(Marketwired - September 16, 2013) - Atossa Genetics Inc. WHO:Atossa Genetics Inc., a Seattle-based healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer WHAT: Breast Health Fair WHEN: Friday, September 27 from 2 to 6 p.m. Saturday, September 28 from 10 a.m.

LOS ANGELES, CA--(Marketwired - Sep 16, 2013) - Seattle-based Atossa Genetics, Inc.